Predictors of phyllodes tumours on core biopsy specimens of fibroepithelial neoplasms

Histopathology

Volumn 57, Issue 2, 2010, Pages 220-232

  Jara Lazaro, Ana Richelia ^a   Akhilesh, Meenakshi ^a   Thike, Aye Aye ^a   Lui, Philip Chi Wai ^b   Tse, Gary Man Kit ^b   Tan, Puay Hoon ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

core biopsy; fibroadenoma; hypercellularity; Ki67; phyllodes tumours; topoisomerase II

Indexed keywords

BIOTIN; CD34 ANTIBODY; DNA TOPOISOMERASE (ATP HYDROLYSING) A; MONOCLONAL ANTIBODY KI 67; PROTEIN BCL 2; STEM CELL FACTOR RECEPTOR; STREPTAVIDIN;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; CELL GROWTH; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYSTOSARCOMA PHYLLOIDES; DIFFERENTIAL DIAGNOSIS; EPITHELIUM HYPERPLASIA; FEMALE; FIBROMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MITOSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; STROMA CELL; TUMOR BIOPSY;

ADULT; AGED; ANTIGENS, CD34; ANTIGENS, NEOPLASM; BIOPSY, NEEDLE; BREAST NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; DNA TOPOISOMERASES, TYPE II; DNA-BINDING PROTEINS; FEMALE; FIBROADENOMA; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MIDDLE AGED; PHYLLODES TUMOR; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

PHYLLODES;

EID: 77955833421     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2010.03607.x     Document Type: Article

References (20)

1. Tan PH, Jayabaskar T, Chuah KL et al. Phyllodes tumours of the breast. The role of pathologic parameters. Am. J. Clin. Pathol. 2005 123 529 540.
2. Lee AHS, Hodi Z, Ellis IO, Elston CW. Histological features useful in the distinction of phyllodes tumour and fibroadenoma on needle core biopsy of the breast. Histopathology 2007 51 336 344.
3. Putti TC, Pinder SE, Elston CW, Lee AHS, Ellis IO. Breast pathology practice: most common problems in consultation service. Histopathology 2005 47 445 457.
4. Noguchi S, Yokouchi H, Aihara T et al. Progression of fibroadenoma to phyllodes tumour demonstrated by clonal analysis. Cancer 1995 76 1779 1785.
5. Jacklin RK, Ridgway PF, Ziprin P, Healy V, Hadjiminas D, Darzi A. Optimizing preoperative diagnosis in phyllodes tumour of the breast. J. Clin. Pathol. 2006 59 454 459.
6. McKenna AM, Pintilie M, Youngson B, Done SJ. Quantification of the morphologic features of fibroepithelial tumours of the breast. Arch. Pathol. Lab. Med. 2007 131 1568 1573.
7. Foxcroft LM, Evans EB, Porter AJ. Difficulties in the pre-operative diagnosis of phyllodes tumours of the breast: a study of 84 cases. Breast 2007 16 27 37.
8. Komenaka IK, El-Tamer M, Pile-Spellman E, Hibshoosh H. Core needle biopsy as a diagnostic tool to differentiate phyllodestumour from fibroadenoma. Arch. Surg. 2003 138 987 990.
9. Tavassoli FA, Devilee P eds. World Health Organization classification of tumours: pathology and genetics of tumours of the breast and female genital organs.
10. Jacobs TW, Connolly JL, Schnitt SJ. Non malignant lesions in breast core needle biopsies. To excise or not to excise? Am. J. Surg. Pathol. 2002 26 1095 1110.
11. Jacobs TW, Yunn-Yi C, Guinee DG et al. Fibroepithelial lesions with cellular stroma on breast core needle biopsy: are there predictors of outcome on surgical excision? Am. J. Clin. Pathol. 2005 3 342 354.
12. Jara-Lazaro AR, Tan PH. Molecular pathogenesis of progression and recurrence in breast phyllodes tumours. Am. J. Transl. Res. 2009 1 23 24.
13. Karim RZ, Scolyer RA, Tse GM, Tan PH, Putti TC, Lee CS. Pathogenic mechanisms in the initiation and progression of mammary phyllodes tumours. Pathology 2009 41 105 117.
14. Tse GMK, Tan PH. Recent advances in the pathology of fibroepithelial tumours of the breast. Curr. Diagn. Pathol. 2005 11 426 434.
15. Niebzabitowski A, Lackowska B, Rys J et al. Prognostic evaluation of proliferative activity and DNA content in the phyllodes tumour of the breast: immunohistochemical and flow cytometric study of 118 cases. Breast Cancer Res. Treat. 2001 65 77 85.
16. Tse GMK, Putti TC, Lui PCW et al. Increased c-kit (CD117) expression in malignant mammary phyllodes tumours. Mod. Pathol. 2004 17 827 831.
17. Tan PH, Jayabaskar T, Yip G et al. p53 and c-kit (CD117) protein expression as prognostic indicators in breast phyllodes tumours: a tissue microarray study. Mod. Pathol. 2005 18 1527 1534.
18. Karim RZ, Gerega SK, Yang YH et al. Phyllodes tumours of the breast: a clinicopathological analysis of 65 cases from a single institution. Breast 2009 18 165 170.
19. Lee AHS. Recent developments in the histological diagnosis of spindle cell carcinoma, fibromatosis and phyllodes tumour of the breast. Histopathology 2008 52 45 57.
20. Jones AM, Springali R, Graham T et al. Phyllodes Tumour Consortium. A comprehensive genetic profile of phyllodes tumours of the breast detects important mutations, intra-tumoural genetic heterogeneity and new genetic changes on recurrence. J. Pathol. 2008 214 533 544.